Sanu Rajendraprasad

Infectious Diseases & Critical care fellow!!

[MayoPCCM @MayoPCCM]

@mayopccm faculty @Luda_Karnatovsk @SumeraAhmad12 @ogi_gajic @JosephSkalski @IDCCMdoc and colleagues @jsung0906 @dRamachandranMD @KfLaudanski @zec_simon @Khanna_S @IDdocAdi talk about kefir's safety and feasibility to mitigate gut dysbiosis in ICU pts

https://t.co/F0Uh4eW2NG

[Andre Kalil, MD MPH @DrAndreKalil]

💥🆕“Society of Critical Care Medicine and Infectious Diseases Society of America Guidelines for Evaluating New Fever in Adult Patients in the ICU”

Our new guideline is published⬇️

#MedTwitter #IDTwitter #TxID #TwitteRx #MedEd #PulmTwitter

👇Free Access
https://t.co/RmEQdsOHY4

[COVID-19 Real-Time Learning Network (RTLN) @RealTimeCOVID19]

Share the facts on #COVID19vaccines & #myocarditis:
❤️ Heart health is safer with the vaccine, despite the rare risk of myocarditis https://t.co/7c5fPnpgWh

[Stefan Milutinovic @stefankmil]

📄 20 studies that Internal Medicine Residents should read in the first year 👇

1/ 🏃‍♀️ RACE II trial: Lenient resting HR < 110 was non-inferior to a strict HR < 80 in patients with atrial fibrillation.

🧵

[Bryan Carmody @jbcarmody]

How much do hospitals receive from the government to train residents?

It depends. There are multiple funding streams and the formulae are complicated.

But here, a consulting firm did the math...

…and estimated that, in 2019, the average Medicare subsidy was $145,435/resident.

[Sanu Rajendraprasad @IDCCMdoc]

https://t.co/EfdDfra44E

@atscommunity @PhillipJGaryMD @CICU_ECHO @intub8_pccm @MayoPCCM

[Sanu Rajendraprasad @IDCCMdoc]

Check out latest ATS quick hits “Under Pressure”

75 yo F with COVID-19. Intubated in MICU followed by shock requiring multiple pressors. LA > 12 & PaO2:FiO2 ratio of 80. ECG:S1Q3T3 & T wave inversion V1 & V2. Poll⬇️

POCUS: Parasternal long & short axis & Apical 4 chamber views

[Sanu Rajendraprasad @IDCCMdoc]

With the above ECG findings & POCUS findings, what would be your immediate next step?

[小谷祐樹 Yuki Kotani｜集中治療医 @YukiKotani5]

New ARDS definition🫁

What's new👇
1⃣HFNO ≥30 L/m
2⃣SpO2/FiO2 ≤315 & SpO2 ≤97
3⃣Ultrasound diagnosis of bilateral opacities
4⃣Consideration for resource-limited settings

But it's hard to know the consensus process from one-page abstract🤔
🔗https://t.co/zsLB5GY2XT
#FOAMcc

[Maria Alejandra Mendoza, MD @MariAleMendozaD]

Music 🎶 to my ears…no urine cultures are needed in asymptomatic patients… even if immunocompromised… Utility of urine cultures during febrile neutropenia workup in hematopoietic stem cell transplantation recipients without urinary symptoms https://t.co/zA0QA7Y2Az

[San Raffaele Anesthesia and Intensive Care @SRAnesthesiaICU]

#Etomidate and mortality in critically ill patients

Etomidate is a common induction agent but controversy exists about its effects on outcomes

Our meta-analysis found a high probability that etomidate increases mortality (NNH 31)

🧵Thread 1/6 🔗https://t.co/50NLXDPqWR #FOAMcc

[Asad Naveed @dr_asadnaveed]

Systematic reviews and meta-analyses are the gold standard for evidence-based healthcare decision-making.

Here are 6 systematic review and meta-analysis courses you can audit for FREE! 🧵

[IMCrit @IM_Crit_]

New guidelines for the management of severe community-acquired pneumonia:

[Mayo Clinic Infectious Diseases @MayoClinicINFD]

#Ibrexafungerp is a first-in-class, triterpenoid antifungal agent used to treat vulvovaginal candidiasis (VVC), and to reduce the incidence of recurrent VVC in adults and adolescent females

It is not active against Fusarium.

https://t.co/c3LuaG5WlU

[Sanu Rajendraprasad @IDCCMdoc]

@Luda_Karnatovsk Appreciated the question and support from the @MayoPCCM family to make this happen. Thank you @Luda_Karnatovsk

[Sanu Rajendraprasad @IDCCMdoc]

@Luda_Karnatovsk crushing a talk on How the type of food can influence the acute illness @Luda_Karnatovsk #ISICEM23 #mayoclinic #mayopccm

[Mayo Clinic Infectious Diseases @MayoClinicINFD]

#MayoClinicIDPracticeUpdates continues with what is new in the pipeline for antifungal therapeutics by @pascalisID #olorofim #fosmanogepix #rezafungin #ibrexafungerp #opelconazole

[Patrick Wieruszewski @pwierusz]

Clonidine for dexmedetomidine separation: systematic review

🧐 observational studies only
🤷🏻‍♂️ variable dosing schema
😵‍💫 more agitation/adverse events w/ clonidine
❓unclear effect on outcomes

https://t.co/Hqtr34oglS

@MayoPCCM @MayoAnesthesia @MayoPharmRes @EDWieru

[Infected Terran, MD @Infected_Terran]

After today's session, will you be getting repeat Bcx for gram negative BSI? #IDTwitter

[Maria Alejandra Mendoza, MD @MariAleMendozaD]

Great summary of the current therapies, love the stepwise approach, good up to date teaching paper also applicable to other immunosuppressed pts:How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies https://t.co/NSiIHgonXa